Financial Shenanigans

Financial Shenanigans — Somero Enterprises (SOM)

Verdict: the reported numbers are a faithful representation of economic reality. Somero's earnings were not "managed" through the 2022–2025 downturn — they fell because demand fell, and the cash statement confirms it line for line. Net income dropped 71% from $34.8m (FY2021) to $10.2m (FY2025), and operating cash flow fell alongside it, with five-year cumulative CFO of $124.7m against $122.8m of cumulative net income (a 1.02 ratio). There is no debt, no acquisition machine, no soft-asset build, no related-party web, no restatement, and no auditor or regulatory issue on the record. The accounting risk here is a footnote, not a valuation haircut.

The two things worth watching are both downturn artifacts, not manipulation: inventory days have inflated to 170 (from 82 in FY2021) while sales fell, and FY2025 operating cash flow leaned on a working-capital harvest (receivable collection plus a near-doubling of payables) that will not repeat once revenue stabilizes. Neither flatters reported earnings.

Source: derived from reported FY2021–FY2025 income statement, cash-flow statement and balance sheet; FY2025 Annual Report Financial Review.

---

The core test: does cash confirm the earnings story?

Yes — emphatically. The single most powerful forensic test pits the income statement against the cash-flow statement, and here they move together: as revenue and net income deteriorated, operating cash flow tracked them down without a gap opening up. In FY2025, CFO of $17.9m actually exceeded net income of $10.2m, producing a negative accrual ratio of -7.9% — the conservative direction. Companies stretching earnings show CFO falling below net income; Somero shows the opposite.

Source: FY2025 Annual Report, Consolidated Statements of Operations and Cash Flows; figures in $M.

Net income fell 71% peak-to-trough — the opposite of the suspiciously-consistent earnings that mark manipulation.

Source: derived from reported cash-flow statement and income statement.

The trough year (FY2025) shows the strongest conversion — but, as the next section shows, part of that is a one-off working-capital release, not durable cash generation.

---

Cash-flow quality: name the mechanism behind FY2025

Strong FY2025 CFO is partly a working-capital harvest, not all recurring cash. The bridge from $10.2m net income to $17.9m CFO runs through depreciation and stock comp (genuine non-cash, ~$3.4m) plus roughly $5.5m of working-capital release: receivables were collected down ($2.3m source), and accounts payable nearly doubled from $3.5m to $6.8m ($3.2m source). That payables stretch and receivable drawdown are downturn behaviours that reverse when activity recovers. Partly offsetting, the company consumed $2.2m building inventory.

Source: derived from FY2025 vs FY2024 balance-sheet movements and the cash-flow statement.

The honest read: underlying, repeatable FY2025 operating cash flow sits closer to net income (~$12m) than to the reported $17.9m. This is a yellow flag (CF4), not a red one — the working-capital release is fully visible in the balance sheet, not buried, and it is the normal mechanics of a contracting capital-equipment business. Capital intensity is trivially low (capex of $0.8m, well under the $2.4m of depreciation), so free cash flow of $17.0m closely tracks CFO with no capitalised-cost games (CF2 clean).

---

Earnings quality: balance sheet vs income statement

Receivables fell faster than sales — the cleanest single signal on the page. If management were pulling revenue forward, receivables would balloon relative to revenue. The opposite happened: FY2025 revenue fell 18.6% while receivables fell 24.6%, a -6.0 percentage-point gap in the conservative direction. Days sales outstanding remain low at ~33 days. There is no contract-asset or unbilled-receivable apparatus to hide behind — Somero sells machines and recognises revenue on delivery.

Source: derived from average receivables/revenue and average inventory/COGS, FY2021–FY2025.

The one genuine balance-sheet deterioration is inventory. Inventory rose to $21.0m (+11.7%) even as revenue fell 19% and COGS fell 15%, pushing days inventory outstanding from 82 days in FY2021 to 170 days in FY2025. Management attributes the build to demand softness and a deliberate buffer. This is a yellow flag on two counts: it ties up working capital, and it raises latent obsolescence risk if the downturn extends. Critically, it does not flatter earnings — there is no evidence of slowing depreciation, capitalised operating cost, or under-reserving; the inventory simply sits on the balance sheet and consumed cash in FY2025.

Margins compressed honestly: gross margin fell from 57.7% (FY2021) to 52.0% (FY2025), which management ties to lost volume scale, unabsorbed overhead and input costs — operating deleverage, not a reserve release dressed up as margin. FY2024 results were modestly flattered by a bad-debt reversal that did not repeat in FY2025 — a reason the year-over-year operating-expense comparison looks slightly worse than the underlying trend.

A modest note on non-operating income (EM3): FY2025 pre-tax income of $15.2m exceeded operating income of $13.9m by $1.26m, driven by a $0.79m foreign-exchange gain plus $0.43m interest income — about 9% of operating income sitting below the line. It is small, disclosed, and management's adjusted EBITDA correctly strips the FX out.

---

The 13-category shenanigans scorecard

Ten of thirteen categories show no clear evidence of strain; three carry low-to-medium yellow flags, all traceable to the cyclical downturn.

Source: forensic assessment of FY2021–FY2025 filings; severity colour green=clean, amber=watch, red=concern.

---

Non-GAAP hygiene: disciplined, not promotional

Somero's adjusted numbers stay within touching distance of GAAP. Adjusted net income of $11.07m sits just 8% above GAAP net income of $10.22m, and diluted adjusted EPS of $0.20 versus GAAP $0.18 is a one-cent difference. The adjustments are conventional and consistently defined year to year: amortisation of intangibles, the tax impact of RSU settlements, and a one-time $0.86m deferred-tax valuation allowance. Adjusted EBITDA adds back the standard items (tax, interest, FX, D&A, stock comp, non-cash lease). There is no "cash earnings" label masquerading as cash flow and no metric that quietly disappeared.

Source: FY2025 Annual Report, Net Income to Adjusted EBITDA / Adjusted Net Income reconciliation.

One caveat: the adjusted figure adds back the $0.86m deferred-tax valuation allowance, a real charge against foreign deferred tax assets. It is a defensible "special item," but a reader underwriting cash taxes should not assume it fully reverses.

---

Breeding ground: governance dampens rather than amplifies

The structural setup reduces, rather than raises, the odds of accounting games. There is no controlling promoter or founder bloc; institutions own roughly 54% of the shares. Compensation is restrained and aligned: executive bonuses are capped at 100% of salary, RSU awards run 40–50% of salary, no director holds options, and the FY2025 bonus paid out at just 33% of target. The dividend was cut roughly 40% (to $0.1024 from $0.1693 per share) under a stated 50%-of-adjusted-net-income payout policy — honest behaviour rather than a payout defended through accounting. Insiders were net buyers (one NED bought 29,000 shares; no selling). There is no debt, so no covenant pressure to manage toward.

Three modest watch-items keep this from being pristine: (1) Non-Executive Chairman Robert Scheuer also chairs the Audit Committee — a combination of roles that is not best practice and slightly dilutes independent challenge over financial reporting; (2) a new CEO (Tim Averkamp) took over in April 2025, the classic setting for a big-bath reset — but no write-offs or impairments were taken; and (3) the company reports semi-annually under AIM rules, so interim granularity is limited. Web and filing searches surfaced no restatement, no auditor resignation, no material weakness, no SEC or regulatory action, and no short-seller report — the only litigation on the record is Somero acting as plaintiff against a competitor (Ligchine) on intellectual property.

---

What to underwrite next

The five highest-value items to monitor:

1. Inventory days (KM2). Watch DIO and the absolute inventory balance in the FY2026 interim and annual report. A reversion toward 120 days as demand recovers would upgrade confidence; a push above 180 days with sales still falling, or any inventory write-down, would downgrade the grade toward Elevated.
2. Repeatable operating cash flow (CF4). Strip the working-capital swing out of FY2026 CFO. If CFO holds near net income once payables and receivables normalise, the FY2025 strength was a one-off, as suspected.
3. Payables normalisation. The near-doubling of accounts payable to $6.8m should partially reverse; if it keeps climbing, probe supplier-terms or liquidity stress (none evident today, with $33.2m net cash and no debt).
4. Gross margin floor. Confirm the 52% gross margin is volume deleverage, not deferred cost; a snap-back as volume returns validates the operational explanation.
5. Audit Committee independence. Watch whether the combined Chairman/Audit-chair role is separated as the board refreshes.

Bottom line: Somero's accounting risk is a footnote to the thesis, not a driver of it. The reported numbers faithfully represent a cash-generative, debt-free business living through a genuine cyclical trough. There is no evidence of earnings manipulation, cash-flow dressing, or metric distortion. Underwrite the demand cycle and the inventory unwind — not the integrity of the financial statements.